Journal of Parkinsons Disease

Papers
(The median citation count of Journal of Parkinsons Disease is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Clinical Trial Highlights: Modulators of Mitochondrial Function132
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention106
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists80
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease66
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?65
A framework to standardize gait study protocols in Parkinson's disease56
When Parkinson's disease interferes in a couple's life: A qualitative study55
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression55
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”52
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort49
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease46
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients46
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”45
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease44
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease44
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease43
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review42
No Higher Risk-Seeking Tendencies or Altered Self-Estimation in a Social Decision-Making Task in Patients with Parkinson’s Disease40
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis40
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease40
What medicines do people with Parkinson's disease want?39
Are Preformed Fibrils a Model of Parkinson’s Disease?39
A possible pathway to freezing of gait in Parkinson's disease36
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease35
The fixel GI Parkinson's research and integrated support model (PRISM)34
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease33
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder33
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative33
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders33
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease31
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?31
Burden of tremor in Parkinson's disease: A survey study29
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy29
Mild cognitive impairment is not predictive of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson's disease29
Twenty-five-year experience with apomorphine pump in Parkinson's disease: A real-life long-term retrospective tolerance study26
Burden, Anxiety, and Depression Among Caregivers of Parkinson’s Disease Patients26
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy26
Surveying Global Availability of Parkinson’s Disease Treatment25
Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease25
Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks25
Mortality and causes of death in patients with Parkinson's disease in Taiwan24
Feasibility and Proof-of-Concept of Delivering an Autonomous Music-Based Digital Walking Intervention to Persons with Parkinson’s Disease in a Naturalistic Setting24
Modulation of Cerebellar Oscillations with Subthalamic Stimulation in Patients with Parkinson’s Disease24
Nomogram for Early Prediction of Parkinson’s Disease Based on microRNA Profiles and Clinical Variables24
Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice23
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease23
Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain22
Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease21
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies21
Deficient Interhemispheric Connectivity Underlies Movement Irregularities in Parkinson’s Disease21
Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia21
The Role of Diet in Parkinson’s Disease21
Acknowledgment to Reviewers 202220
Metabolic connectivity of freezing in Parkinson's disease20
Hidden Gems in Neurology: The Syndrome of Hemiparkinsonism-Hemiatrophy20
A glimpse of the end-of-life of people with Parkinson's disease and atypical parkinsonism: A descriptive analysis of electronic health records20
Atypical parkinsonian syndromes in French Guiana: Similarities and differences with Caribbean variants19
Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay19
Gait Declines Differentially in, and Improves Prediction of, People with Parkinson’s Disease Converting to a Freezing of Gait Phenotype19
Motor Memory Consolidation Deficits in Parkinson’s Disease: A Systematic Review with Meta-Analysis19
Effects of Low-Intensity Vestibular Noise Stimulation on Postural Instability in Patients with Parkinson’s Disease18
Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's disease18
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population18
Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review18
A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults18
Recruitment for Remote Decentralized Studies in Parkinson’s Disease18
“Tip-of-the-Tongue” Phenomenon in Parkinson’s Disease: A Hidden Gem18
Non-Pharmacological Interventions for People with Parkinson’s Disease: Are We Entering a New Era?18
Do Impulse Control Disorders Impair Car Driving Performance in Patients with Parkinson’s Disease?18
Symmetric and Profound Monoaminergic Degeneration in Parkinson’s Disease with Premotor REM Sleep Behavior Disorder18
Parkinson’s Pals: A Student-Led Program to Facilitate Intergenerational Connections and Promote Psychosocial Well-Being Among Persons with Parkinson’s Disease18
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?17
Enhancing Participant Engagement in Clinical Studies: Strategies Applied in the Personalized Parkinson Project17
Sex-specific progression of Parkinson's disease: A longitudinal mixed-models analysis17
Structural-Functional Correlates of Response to Pedunculopontine Stimulation in a Randomized Clinical Trial for Axial Symptoms of Parkinson’s Disease17
Enhancing Trial Delivery in Parkinson’s Disease: Qualitative Insights from PD STAT17
Specialized Allied Health Care for Parkinson’s Disease: State of the Art and Future Directions17
Tackling Parkinson’s Disease as a Global Challenge17
Buspirone regulates cortico-striatal gamma oscillations to ameliorate dyskinesia17
Integrating virtual reality into multidisciplinary care for Parkinson's disease: A narrative review17
Anxiety-related attentional characteristics and their relation to freezing of gait in people with Parkinson's: Cross-validation of the Adapted Gait Specific Attentional Profile (G-SAP)17
Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life17
Utility of a newly created questionnaire on subtle motor symptoms in high-risk subjects with Parkinson's disease16
Incretin Mimetics Restore the ER-Mitochondrial Axis and Switch Cell Fate Towards Survival in LUHMES Dopaminergic-Like Neurons: Implications for Novel Therapeutic Strategies in Parkinson’s Disease16
Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot Study16
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model16
The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s Disease16
Enhancing the diagnostic potential of electroretinography in Parkinson's disease: A review of protocol and cohort criteria16
Unveiling the neural network of freezing of gait in Parkinson's disease: A coordinate-based network study16
Kinematic Effects of Combined Subthalamic and Dorsolateral Nigral Deep Brain Stimulation in Parkinson’s Disease15
A Practical Guide to the Evaluation of Compensation Strategies for Gait Impairment in Parkinson’s Disease15
Remote Delivery of Allied Health Therapies in Parkinson’s Disease15
Feasibility and acceptability of PDConnect, a multi-component intervention to support physical activity in people with Parkinson's disease: A mixed methods study15
Unmet needs in the pharmacological management of motor symptoms in Parkinson's disease15
Evaluating the Psychometric Properties of the Psychological Capital Questionnaire (PCQ) in Patients with Parkinson’s Disease15
Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson’s Disease and Other Synucleinopathies15
Designing the First Trials for Parkinson’s Prevention15
40-Year Incidence of Early-Onset Parkinson’s Disease in Southeast Minnesota14
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson’s Disease14
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease14
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease14
Natural Health Products for Symptomatic Relief of Parkinson’s Disease: Prevalence, Interest, and Awareness14
Gender Distribution in Deep Brain Stimulation for Parkinson’s Disease: The Effect of Awake versus Asleep Surgery14
Discontinuation or acute unplanned cessation of oral dopaminergic medications in persons with Parkinson's disease: A practice review14
Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson’s Disease14
Diffuse putaminal degeneration without iron deposition in multiple system atrophy14
Neurodegeneration of the Globus Pallidus Internus as a Neural Correlate to Dopa-Response in Freezing of Gait14
Trichloroethylene: An Invisible Cause of Parkinson’s Disease?14
Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity14
Reduced Thickness of the Retina in de novo Parkinson’s Disease Shows A Distinct Pattern, Different from Glaucoma14
Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders14
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson’s Disease14
Advice to People with Parkinson’s in My Clinic: Orthostatic Hypotension13
Fatigue in de novo Parkinson’s Disease: Expanding the Neuropsychiatric Triad?13
Pediatric-onset PRKN disease: New insights into an understudied population13
Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies13
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease13
Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms13
Can People with Parkinson’s Disease Self-Trigger Gait Initiation? A Comparison of Cueing Strategies13
Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients13
Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation13
Risk of Neurodegeneration in Patients with Rapid Eye Movement Sleep Behavior Disorder13
Inflammasome Activation in Parkinson’s Disease13
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation13
Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson’s Disease as a Multi-System Process13
Spinal Cord Stimulation for Gait Disorders in Parkinson’s Disease13
The Role of Pathogens and Anti-Infective Agents in Parkinson’s Disease, from Etiology to Therapeutic Implications13
New insights from a Malaysian real-world deep brain stimulation cohort12
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease12
Assessing the Role of Locus Coeruleus Degeneration in Essential Tremor and Parkinson’s Disease with Sleep Disorders12
Obstructive sleep apnea, periodic limb movements, and REM sleep without atonia are common in Parkinson's disease and correlate with motor symptom burden12
Impaired Inhibitory Control During Walking in Parkinson’s Disease Patients: An EEG Study12
The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson’s Disease12
Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study12
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease12
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson’s Disease12
Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: A Surgicogenomic Approach12
How Information Affects Patients with Parkinson’s Disease: A Scoping Review of the Literature11
Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease11
Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group11
Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease11
Letter to the Editor: Is It Too Early to Underrate Genetics onto PD Pathogenesis? Reflections on History11
Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle11
The potential of distributed diagnostics for the early detection of Parkinson's disease11
Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease11
Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease11
Acknowledgment to Reviewers 202311
Pain Fluctuations in Parkinson’s Disease and Their Association with Motor and Non-Motor Fluctuations11
RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions11
Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson’s Disease Trials11
Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson’s Disease with Cognitive Impairment: A Proof-of-Concept Study10
Preparing for Parkinson’s disease prevention trials: Current progress and future directions10
Relating movement behaviours and non-motor characteristics in people with Parkinson's disease: A compositional data analysis approach10
The impact of diet on Parkinson's disease risk: A data-driven analysis in a large Italian case-control population10
Retrograde Procedural Memory in Parkinson’s Disease: A Cross-Sectional, Case-Control Study10
A PLAN to address the Parkinson pandemic10
PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy10
Worsening of Parkinson’s Disease After Termination of COVID-19 Quarantine Cannot Be Reversed Despite Resumption of Physiotherapy10
Machine Learning-Based Classification of Parkinson’s Disease Patients Using Speech Biomarkers10
Oscillation-Specific Nodal Differences in Parkinson’s Disease Patients with Anxiety10
Increasing trends in utilization of physical and occupational therapy services in early Parkinson's disease10
Hypomimia May Influence the Facial Emotion Recognition Ability in Patients with Parkinson’s Disease10
Personality Changes After Subthalamic Nucleus Stimulation in Parkinson’s Disease10
Motor outcomes in unilateral, bilateral rapid, and bilateral delayed staging deep brain stimulation for Parkinson’s disease10
Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk10
Disease Progression of Data-Driven Subtypes of Parkinson’s Disease: 5-Year Longitudinal Study from the Early Parkinson’s Disease Longitudinal Singapore (PALS) Cohort10
Development of a Screening Tool for Assessing Sexual Difficulties Among Patients with Parkinson’s Disease: The PD-SDS9
Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic9
Factors Associated with Preferred Place of Care and Death in Patients with Parkinson’s Disease: A Cross-Sectional Study9
Colonoscopy and Subsequent Risk of Parkinson’s Disease9
Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms9
Parkinson's disease participant-led research on the impact of deep brain stimulation frequency9
Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease9
Association Between Menopausal Hormone Therapy and Risk for Parkinson’s Disease9
Diverse preferences, different solutions: Exploring remote monitoring preferences in Parkinson's disease through a discrete choice experiment9
Addressing the “Replication Crisis” in the Field of Parkinson’s Disease9
Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials9
Screening Tools for Sarcopenia in Mild to Moderate Parkinson’s Disease: Assessing the Accuracy of SARC-F and Calf Circumference9
Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson’s Disease9
Reaching and Grasping Movements in Parkinson’s Disease: A Review9
Lactobacillaceae and Parkinson's disease: An apparent paradox9
Neural Oscillations and Functional Significances for Prioritizing Dual-Task Walking in Parkinson’s Disease9
Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder9
The Impact of Motor, Non-Motor, and Social Aspects on the Sexual Health of Men Living with Parkinson’s Disease9
Concordance between imaging and clinical based STN-DBS programming improves motor outcomes of directional stimulation in Parkinson's disease9
Insights on Genetic and Environmental Factors in Parkinson’s Disease from a Regional Swedish Case-Control Cohort9
Structural Connectivity of Subthalamic Nucleus Stimulation for Improving Freezing of Gait9
Dengue Virus Infection and Risk of Parkinson’s Disease: A Nationwide Longitudinal Study9
PARKinSOUND: Impact of participation in an orchestra in patients with Parkinson's disease8
Premorbid Educational Attainment and Long-Term Motor Prognosis in Parkinson’s Disease8
mHealth-assisted expiratory muscle strength training in Parkinson's disease patients: A proof-of-concept study8
Declining trends in the incidence of Parkinson's disease: A cohort study in Germany8
Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder8
Fear of Progression is Determined by Anxiety and Self-Efficacy but not Disease-Specific Parameters in Patients with Parkinson’s Disease: Preliminary Data from a Multicenter Cross-Sectional Study8
Immunogenetic Determinants of Parkinson’s Disease Etiology8
Cognitive Effects of Three β-Adrenoceptor Acting Drugs in Healthy Volunteers and Patients with Parkinson’s Disease8
Surface electromyographic profiles during gait initiation in people with Parkinson's disease: The effects of external sensory cueing8
Sleep Disorders in Early-Onset Parkinsonism: A Population-Based Study8
Chronotropic Incompetence During Exercise Testing as a Marker of Autonomic Dysfunction in Individuals with Early Parkinson’s Disease8
The Effect of a Structured Medication Review on Quality of Life in Parkinson’s Disease8
The Etiology of Parkinson’s Disease: New Perspectives from Gene-Environment Interactions7
Association Between Parkinson’s Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis7
Stochastic Epigenetic Mutations Influence Parkinson’s Disease Risk, Progression, and Mortality7
Neuropsychiatric Symptoms and Caregiver Stress in Parkinson’s Disease with Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia7
Tackling gender in progressive supranuclear palsy: Male patients present more apathy7
Gaps in the Parkinson's disease therapeutic clinical pipeline: A focus on approaches targeting disease pathobiology7
Considerations on How to Prevent Parkinson’s Disease Through Exercise7
The Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease on Associative Learning of Verbal and Non-Verbal Information by Trial and Error or with Corrective Feedback7
Video-Based Automated Assessment of Movement Parameters Consistent with MDS-UPDRS III in Parkinson’s Disease7
Ankylosing Spondylitis: A Risk Factor for Parkinsonism—A Nationwide Population-Based Study7
Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop7
Advice to people with Parkinson's in my clinic: Get a cardiopulmonary exercise test7
Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson’s Disease7
Evaluation of the Impact of Integrated Care and Self-Management After Deep Brain Stimulation in Parkinson’s Disease7
Evaluation of Bedside Tests of Attention and Arousal Assessing Delirium in Parkinson’s Disease, Dementia, and Older Adults7
The Role of Monoaminergic Tones and Brain Metabolism in Cognition in De Novo Parkinson’s Disease7
Pain and the Non-Pharmacological Management of Pain in People with Parkinson’s Disease7
Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease7
Clinical Trial Highlights – Interventions Promoting Physical Activity in Parkinson’s Disease7
“No One Can Tell Me How Parkinson’s Disease Will Unfold”: A Mixed Methods Case Study on Palliative Care for People with Parkinson’s Disease and Their Family Caregivers7
An Evaluation of KELVIN, an Artificial Intelligence Platform, as an Objective Assessment of the MDS UPDRS Part III7
Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson’s Disease7
Reading Difficulties in Parkinson’s Disease: A Stepped Care Model for Neurovisual Rehabilitation7
Hidden Gems in the Neurological Literature of Progressive Supranuclear Palsy7
Visualization of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale Results7
The proSAAS Chaperone Provides Neuroprotection and Attenuates Transsynaptic α-Synuclein Spread in Rodent Models of Parkinson’s Disease7
Pilot Study Results Assessing the Accuracy of a Ballistic Sleep Monitor Relative to Polysomnography in Parkinson’s Disease7
New Journal Section: Hidden Gems from the Literature of Parkinson’s Disease7
A Randomized, Double-Blinded Crossover Trial of Short Versus Conventional Pulse Width Subthalamic Deep Brain Stimulation in Parkinson’s Disease7
Advice to people with Parkinson's in my clinic: How to manage running-induced dystonia6
Parkinson's disease associated with LRRK2 -R1441C mutation: Characterization and comparison with other LRRK2 mutations6
Risk Factors for Postoperative Delirium Severity After Deep Brain Stimulation Surgery in Parkinson’s Disease6
The Cause and Duration of Emergency Admissions to Hospital in People with Idiopathic Parkinson’s Disease, Under the Care of a UK Service, During the First Year of the COVID-19 Pandemic6
Cost-Effectiveness Analyses of Non-Pharmacological and Non-Surgical Interventions in Idiopathic Parkinson’s Disease: A Systematic Review6
Pointing in the right direction: Greater motor improvements with directional versus circular subthalamic nucleus deep brain stimulation for Parkinson's disease6
Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity6
Is motor reserve associated with a rapid progression of Parkinson disease?6
Gut microbial shifts toward inflammation in Parkinson's disease: Insights from pilot shotgun metagenomics Egyptian cohort6
The Importance of Digital Health Literacy in an Evolving Parkinson’s Disease Care System6
Digital Intervention Promoting Physical Activity in People Newly Diagnosed with Parkinson’s Disease: Feasibility and Acceptability of the Knowledge, Exercise-Efficacy and Participation (KEEP) Interven6
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update6
Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson’s Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis6
Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial6
Corrigendum to “Parkinsonian Hand or Clinician’s Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts”6
Autopallidotomy: From Colloquial Term to Scientific Theory6
Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study6
A Randomized Controlled Trial of Fecal Microbiota Transplantation for Parkinson’s Disease: Getting it right, if not PARFECT6
The impact of motor, non-motor, and social aspects on the sexual health of women living with Parkinson's disease6
A Retrospective Comparison of Multiple Approaches to Anatomically Informed Contact Selection in Subthalamic Deep Brain Stimulation for Parkinson’s Disease6
Exploring the Complex Phenotypes of Impaired Finger Dexterity in Mild-to-moderate Stage Parkinson’s Disease: A Time-Series Analysis6
0.076186180114746